Michael Klichinsky
Gründer bei CARISMA THERAPEUTICS, INC.
Vermögen: 794 329 $ am 30.04.2024
Aktive Positionen von Michael Klichinsky
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CARISMA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2022 | - |
Gründer | 01.01.2016 | - | |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2022 | - |
Gründer | 01.01.2016 | - | |
Corporate Officer/Principal | 01.10.2018 | 01.04.2022 |
Karriereverlauf von Michael Klichinsky
Ausbildung von Michael Klichinsky
University of Pennsylvania | Doctorate Degree |
University of the Sciences in Philadelphia | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Doctorate Degree | 2 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CARISMA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
- Börse
- Insiders
- Michael Klichinsky
- Erfahrung